Maze Therapeutics (MAZE) Misses Q4 EPS by 65c
Tweet
Share
E-mailGet Alerts MAZE Hot Sheet
Join SI Premium – FREE
Maze Therapeutics (NASDAQ: MAZE) reported Q4 EPS of ($0.65).
For earnings history and earnings-related data on Maze Therapeutics (MAZE) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- S&P Dow Jones Indices adds Bloom Energy to S&P 500 index
- Huntington Ingalls wins $336 million Navy contract for CVN 82
- Boeing wins $241 million Navy contract for aircraft repairs
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
